{"id":"W3217773060","doi":"10.2217/nmt-2021-0042","title":"MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Amyotrophic lateral sclerosis; Tolerability; Medicine; Neuroprotection; Riluzole; Quality of life (healthcare); Placebo; Clinical trial; Context (archaeology); Disease; Pharmacology; Internal medicine; Oncology; Adverse effect; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008563447,0.0005799643,0.0009346566,0.000668214,0.0001898273,0.0002267085,0.000376824,0.00005785723,0.0005882899],"category_scores_gemma":[0.0001375179,0.0005356539,0.0001867613,0.001754261,0.0001179903,0.0002540711,0.0007652064,0.0005932441,0.0001020976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004808614,"about_ca_system_score_gemma":0.0002121449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001155271,"about_ca_topic_score_gemma":0.0001830032,"domain_scores_codex":[0.9928471,0.002099171,0.001041485,0.001634042,0.001415642,0.000962604],"domain_scores_gemma":[0.9977921,0.00009964932,0.0001297828,0.001149755,0.0002231624,0.0006055788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01481117,0.1349536,0.6715164,0.0005223994,0.001779368,0.08277002,0.008172904,0.02190336,0.03713307,0.0007050464,0.007523688,0.01820903],"study_design_scores_gemma":[0.03458735,0.002861045,0.9542092,0.0002377192,0.0002693465,0.000003987875,0.001454026,0.005120684,0.000499974,0.0000788036,0.0001826302,0.0004951975],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898465,0.0002805522,0.0001966568,0.002439008,0.0002016978,0.006643366,0.00003605757,0.00009073261,0.0002654655],"genre_scores_gemma":[0.994392,0.0001729602,0.0001800584,0.001692182,0.00006985311,0.001699876,0.00008371278,0.00009574131,0.001613554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2826929,"threshold_uncertainty_score":0.9997095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08541449983593444,"score_gpt":0.3447099443251491,"score_spread":0.2592954444892147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}